Zelos Therapeutics specializes in the development of innovative treatments for bone disorders and related indications in large, underserved markets. Led by an experienced team of biopharmaceutical executives and funded by leading health care investors, Zelos is advancing a portfolio of product opportunities into late stage clinical trials.
We are pursuing programs linked by the common mechanism of stimulating bone formation to provide therapeutic benefit in the following key indications:
